| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/25/2009 | CA2708324A1 Viral polymerase inhibitors |
| 06/25/2009 | CA2707988A1 Novel pyrazole-substituted arylamides |
| 06/25/2009 | CA2707785A1 Indoles and their therapeutic use |
| 06/25/2009 | CA2706839A1 Aminotriazole derivatives as alx agonists |
| 06/24/2009 | EP2072509A1 1-Aryl-1H-quinoline-2-ones: process for their production and their use as anti-inflammatory agents |
| 06/24/2009 | EP2072062A1 The use of the spin crossover complex [M*+ (L2) Hw]AN)2 as a magnetic resonance imaging contrast agent |
| 06/24/2009 | EP1963304B1 Isoquinoline derivatives |
| 06/24/2009 | EP1863812A4 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 06/24/2009 | EP1205559B1 Method for detecting pathogenic microorganisms and antimicrobial agents, method for evaluating the drug effect of antimicrobial agents, and antimicrobial agents |
| 06/24/2009 | CN101466702A Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents |
| 06/24/2009 | CN101466701A Crystalline forms of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline |
| 06/24/2009 | CN101466700A Triazine derivatives containing amino and carboxylic acic group |
| 06/24/2009 | CN101466699A Pyrrole derivatives with CRTH2 receptor modulator activity |
| 06/24/2009 | CN101466698A Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 06/24/2009 | CN100503600C Pesticidal heterocycles |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503598C Improved chemical process and pharmaceutical formulation |
| 06/24/2009 | CN100503597C Enantioselective alkylation of tricyclic compounds |
| 06/24/2009 | CN100503596C Process for purifying 6-methoxy omeprazole |
| 06/24/2009 | CN100503576C Substituted azole compounds, preparation and application thereof |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/24/2009 | CN100503562C Pyrrolidone derivatives as MAOB inhibitors |
| 06/24/2009 | CN100502874C Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 06/23/2009 | USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide |
| 06/23/2009 | US7550599 for stabilizing aqueous polymer systems (water borne coatings, aqueous inks, aqueous ink jet media, and photocured aqueous systems) against oxidative, thermal and actinic radiation |
| 06/23/2009 | US7550597 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 06/23/2009 | US7550591 4-(4-methyl-piperazin-1-ylmethyl-benzoic acid with N-(5- amino-2-methylphenyl)-4-(3pyridyl)-2-pyrimidine-amine in the presence of a coupling reagent such as 2-(5-norborene-2,3- dicarboximido)- 1,1,3,3-tetramethyluronium tetrafluoroborate to produce imatinib, salt formation wtih methanesululfonic acid |
| 06/23/2009 | US7550590 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 06/23/2009 | US7550570 4,7-dichlororhodamine dyes labeled polynucleotides |
| 06/23/2009 | US7550499 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/23/2009 | US7550496 Hypoxia-activated prodrugs of alkylating agents such as of cyclophosphamide, ifosfamide, melphalan, chlorambucil, thiotepa; protected with 2-nitroimidazolyl group; targeted cancer cells more effectively, side effect reduction |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550487 Factor Xa inhibitors; anticoagulants; thrombotic disorders; (3R,4R)-3-(4-Chloro-phenylcarbamoyl)-4-[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-pyrrolidine-1-carboxylic acid propyl ester for example |
| 06/23/2009 | US7550486 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 06/23/2009 | US7550484 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine |
| 06/23/2009 | US7550481 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 06/23/2009 | US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/23/2009 | US7550463 Carbamoylpyridone derivatives having inhibitory activity against HIV integrase |
| 06/23/2009 | US7550462 3-(2,3-dihydro-1H-inden-2-yl)-1-[1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[1-methylpropyl]-2,5-piperazinedione and acid addition salts thereof; pre-term labour, dysmenorrhea, endometriosis and benign prostatic hyperplasia, sexual disorders, fertility in farm animals |
| 06/23/2009 | US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | CA2535920C Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 06/23/2009 | CA2522220C Cgrp receptor antagonists |
| 06/23/2009 | CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/23/2009 | CA2405046C Stabilized pharmaceutical compositions comprising a calcium blocker and an alkaline material |
| 06/23/2009 | CA2384354C Pyrimidine derivatives and herbicides containing them |
| 06/23/2009 | CA2347506C Quinazolinone derivatives |
| 06/23/2009 | CA2326833C Indolyl-3-glyoxylic acid derivatives with antitumoral activity |
| 06/23/2009 | CA2245080C Process for the preparation of heteroarylcarboxylic amides and esters |
| 06/18/2009 | WO2009076631A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 06/18/2009 | WO2009076602A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076571A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076404A1 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 06/18/2009 | WO2009076387A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 06/18/2009 | WO2009075874A1 Gamma secretase modulators |
| 06/18/2009 | WO2009075835A1 CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1 |
| 06/18/2009 | WO2009075516A2 Process for preparing pantoprazole sodium sesquihydrate |
| 06/18/2009 | WO2009075504A2 Crystalline form of bepotastine p-toluenesulfonate, method for preparing same and pharmaceutical composition containing same |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 06/18/2009 | WO2009074782A1 Cannabinoid receptor modulators |
| 06/18/2009 | WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | WO2009074675A1 Fluorescent, heterocyclic annellated perylene |
| 06/18/2009 | WO2009074590A1 N- (2 { [1-phenyl-1h-indaz0l-4-yl] amino} propyl) -sulfonamide derivatives as non-steroidal glucocorticoid receptor ligands for the treatment of inflammations |
| 06/18/2009 | WO2009074300A2 Hedgehog pathway antagonists and therapeutic applications thereof |
| 06/18/2009 | WO2009074019A1 Proteinase inhibitors useful for treating cancer |
| 06/18/2009 | WO2009073973A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/18/2009 | WO2009036996A3 Small molecule bradykinin b1 receptor antagonists |
| 06/18/2009 | WO2009016215A3 N-aryl-n-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/18/2009 | WO2009016214A3 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/18/2009 | WO2008122858A9 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals |
| 06/18/2009 | WO2008099000A3 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 06/18/2009 | WO2008072053A8 Substituted arylpyrazoles |
| 06/18/2009 | WO2007124337A8 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090158019 Computer Program Code Size Partitioning System for Multiple Memory Multi-Processing Systems |
| 06/18/2009 | US20090156821 Quinazoline compounds |
| 06/18/2009 | US20090156813 Methods of preparing aripiprazole crystalline forms |
| 06/18/2009 | US20090156809 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 06/18/2009 | US20090156642 5-Membered heterocyclic compound |
| 06/18/2009 | US20090156641 Inhibition of cyclooxygenase-2 activity |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156635 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators |
| 06/18/2009 | US20090156623 N-aryl piperidine substituted biphenylcarboxamides |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156615 Organic compounds |
| 06/18/2009 | US20090156613 Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor |
| 06/18/2009 | US20090156604 Fused bicyclic imidazoles |
| 06/18/2009 | US20090156601 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 2-(3-hydroxyphenyl)-4-(morpholin-4-yl)-6-(pyridin-3-ylmethylamino) pyrimidine |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156592 Fungicidal Azocyclic Amides |
| 06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
| 06/18/2009 | US20090156586 Compounds for the treatment of inflammatory disorders |
| 06/18/2009 | US20090156577 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 06/18/2009 | US20090156576 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases |
| 06/18/2009 | US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents |
| 06/18/2009 | US20090156572 Nitrogen-containing heterocyclic compound and use thereof |